Global IVD Market to be Worth US$ 52 Billion by 2013
Factors, such as adoption of new IVD equipments and technological advancements will create a US$ 52 Billion global IVD market by 2013 end, RNCOS acknowledged.

Currently, the global IVD market is dominated by regions, such as North America, Europe, and Japan, which collectively occupy around 80% share of the total market. In North America, United States has the largest share, which is also a largest IVD market in world. Germany accounts for a 21% share of the total market in Europe, followed by France and Italy. Japan is the world's third-largest IVD market, with an estimated 309 Billion Yen size in 2009.
The report "Global In Vitro Diagnostic Market Analysis" divides the overall IVD market into key segments and provides all the important statistic and developments. The report also covers a description regarding key market drivers, which have been boosting the market potential and will provide a growth momentum in future. The current scenario and future projection of IVD market in key indications have also been provided. Diseases, such as diabetes, cancer, HIV, tuberculosis, and cardiovascular have been analyzed in an effective manner in this regard.
The report is an outcome of an extensive research and prudent analysis of the global IVD market that properly identifies the recent industry developments and analyzes their impact on market performance. The forecast in key areas of the report makes use of effective methods and techniques that seek to present a realistic view of the future outlook. Last though not the least, a proper coverage of key market players and their recent activities complete the overall industry analysis.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM103.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm
About RNCOS:
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.
###
Categories: Health
Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707